Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Oncology Based Molecular Diagnostics market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Oncology Based Molecular Diagnostics market segmented into
PCR
Multiplex PCR
In Situ Hybridization
Isothermal Nucleic Acid Amplification Technology (INAAT)
Based on the end-use, the global Oncology Based Molecular Diagnostics market classified into
Breast Cancer
Prostate Cancer
Colorectal Cancer
Cervical Cancer
Others
Based on geography, the global Oncology Based Molecular Diagnostics market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Abbott Laboratories
Bayer Healthcare
Becton Dickinson
Cepheid
Dako
Danaher Corporation
Gen Probe(Hologic)
Roche Diagnostics
Siemens Healthcare
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ONCOLOGY BASED MOLECULAR DIAGNOSTICS INDUSTRY
2.1 Summary about Oncology Based Molecular Diagnostics Industry
2.2 Oncology Based Molecular Diagnostics Market Trends
2.2.1 Oncology Based Molecular Diagnostics Production & Consumption Trends
2.2.2 Oncology Based Molecular Diagnostics Demand Structure Trends
2.3 Oncology Based Molecular Diagnostics Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 PCR
4.2.2 Multiplex PCR
4.2.3 In Situ Hybridization
4.2.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Breast Cancer
4.3.2 Prostate Cancer
4.3.3 Colorectal Cancer
4.3.4 Cervical Cancer
4.3.5 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 PCR
5.2.2 Multiplex PCR
5.2.3 In Situ Hybridization
5.2.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Breast Cancer
5.3.2 Prostate Cancer
5.3.3 Colorectal Cancer
5.3.4 Cervical Cancer
5.3.5 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 PCR
6.2.2 Multiplex PCR
6.2.3 In Situ Hybridization
6.2.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Breast Cancer
6.3.2 Prostate Cancer
6.3.3 Colorectal Cancer
6.3.4 Cervical Cancer
6.3.5 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 PCR
7.2.2 Multiplex PCR
7.2.3 In Situ Hybridization
7.2.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Breast Cancer
7.3.2 Prostate Cancer
7.3.3 Colorectal Cancer
7.3.4 Cervical Cancer
7.3.5 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 PCR
8.2.2 Multiplex PCR
8.2.3 In Situ Hybridization
8.2.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Breast Cancer
8.3.2 Prostate Cancer
8.3.3 Colorectal Cancer
8.3.4 Cervical Cancer
8.3.5 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 PCR
9.2.2 Multiplex PCR
9.2.3 In Situ Hybridization
9.2.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Breast Cancer
9.3.2 Prostate Cancer
9.3.3 Colorectal Cancer
9.3.4 Cervical Cancer
9.3.5 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Abbott Laboratories
10.1.2 Bayer Healthcare
10.1.3 Becton Dickinson
10.1.4 Cepheid
10.1.5 Dako
10.1.6 Danaher Corporation
10.1.7 Gen Probe(Hologic)
10.1.8 Roche Diagnostics
10.1.9 Siemens Healthcare
10.2 Oncology Based Molecular Diagnostics Sales Date of Major Players (2017-2020e)
10.2.1 Abbott Laboratories
10.2.2 Bayer Healthcare
10.2.3 Becton Dickinson
10.2.4 Cepheid
10.2.5 Dako
10.2.6 Danaher Corporation
10.2.7 Gen Probe(Hologic)
10.2.8 Roche Diagnostics
10.2.9 Siemens Healthcare
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Table
1.Table Oncology Based Molecular Diagnostics Product Type Overview
2.Table Oncology Based Molecular Diagnostics Product Type Market Share List
3.Table Oncology Based Molecular Diagnostics Product Type of Major Players
4.Table Brief Introduction of Abbott Laboratories
5.Table Brief Introduction of Bayer Healthcare
6.Table Brief Introduction of Becton Dickinson
7.Table Brief Introduction of Cepheid
8.Table Brief Introduction of Dako
9.Table Brief Introduction of Danaher Corporation
10.Table Brief Introduction of Gen Probe(Hologic)
11.Table Brief Introduction of Roche Diagnostics
12.Table Brief Introduction of Siemens Healthcare
13.Table Products & Services of Abbott Laboratories
14.Table Products & Services of Bayer Healthcare
15.Table Products & Services of Becton Dickinson
16.Table Products & Services of Cepheid
17.Table Products & Services of Dako
18.Table Products & Services of Danaher Corporation
19.Table Products & Services of Gen Probe(Hologic)
20.Table Products & Services of Roche Diagnostics
21.Table Products & Services of Siemens Healthcare
22.Table Market Distribution of Major Players
23.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
24.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
25.Table Global Oncology Based Molecular Diagnostics Market Forecast (Million USD) by Region 2021f-2026f
26.Table Global Oncology Based Molecular Diagnostics Market Forecast (Million USD) Share by Region 2021f-2026f
27.Table Global Oncology Based Molecular Diagnostics Market Forecast (Million USD) by Demand 2021f-2026f
28.Table Global Oncology Based Molecular Diagnostics Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Oncology Based Molecular Diagnostics Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Oncology Based Molecular Diagnostics Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Oncology Based Molecular Diagnostics Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Oncology Based Molecular Diagnostics Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Oncology Based Molecular Diagnostics Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Oncology Based Molecular Diagnostics Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Oncology Based Molecular Diagnostics Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure PCR Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Multiplex PCR Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure In Situ Hybridization Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Isothermal Nucleic Acid Amplification Technology (INAAT) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Breast Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Colorectal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Cervical Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure PCR Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Multiplex PCR Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure In Situ Hybridization Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Isothermal Nucleic Acid Amplification Technology (INAAT) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Breast Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Colorectal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Cervical Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure PCR Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Multiplex PCR Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure In Situ Hybridization Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Isothermal Nucleic Acid Amplification Technology (INAAT) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Breast Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Colorectal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Cervical Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure PCR Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Multiplex PCR Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure In Situ Hybridization Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Isothermal Nucleic Acid Amplification Technology (INAAT) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Breast Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Colorectal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Cervical Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure PCR Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Multiplex PCR Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure In Situ Hybridization Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Isothermal Nucleic Acid Amplification Technology (INAAT) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Breast Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over
